Search results
Acute Respiratory Distress Syndrome (ARDS): What to Know
Verywell Health via Yahoo News· 5 months agoAcute respiratory distress syndrome (ARDS) is a serious complication you could experience after some...
22-Year-Old Who Vaped Heavily Spent 70 Days On Life Support, Needed Double Lung Transplant
People via Yahoo News· 4 months agoThe family of Jackson Allard, 22, said he “had no idea how bad” vaping was for him vape Jackson...
Thermo Fisher's (TMO) PPD Business Backs BARDA's Clinical Trial
Zacks via Yahoo Finance· 5 months agoThermo Fisher Scientific’s TMO PPD clinical research business has been recently selected by the...
‘I thought it was a bad cold - I ended in intensive care with sepsis’
The Independent UK via AOL· 8 months agoA woman has revealed a picture of her in intensive care with sepsis - so severe she had to learn to...
Akebia's Anemia Drug Disappoints In Mid-Stage COVID-19 Study
Benzinga via Yahoo Finance· 2 years agoAkebia Therapeutics Inc (NASDAQ: AKBA) announced initial findings from an investigator-sponsored...
Inspira (IINN) Advances Foothold in Europe With Extended Deal
Zacks via Yahoo Finance· 9 months agoInspira Technologies OXY B.H.N. Ltd. IINN, a major player in the field of acute respiratory care...
Misplaced breathing tube ‘contributed to death’ of first UK child Covid victim
Press Association News via AOL· 1 year agoA misplaced breathing tube contributed to the death of a 13-year-old boy who became the UK’s first...
Inquest into death of first UK child Covid victim told of breathing tube error
Press Association News via AOL· 1 year agoA breathing tube in the wrong position could have contributed to the death of a 13-year-old boy who...
Veru Seeks FDA Emergency Use Nod For Its COVID-19 Treatment
Benzinga via Yahoo Finance· 2 years agoVeru Inc (NASDAQ: VERU) has submitted an emergency use authorization (EUA) for sabizabulin...
Edesa Biotech's COVID-19 Candidate Restraints Inflammation From Influenza, Other Pathogens In...
Benzinga via Yahoo Finance· 11 months agoEdesa Biotech Inc (NASDAQ: EDSA) released findings from an in vitro study involving its monoclonal...